Your email has been successfully added to our mailing list.

×
-0.00346620450606584 -0.00346620450606584 0.0018955805892548 -0.0087738301559792 0.00194974003466207 0.00736568457538998 -0.0142980935875217 -0.00888214904679374
Stock impact report

Tracon Pharma up 17% premarket on rights to cancer candidate TRC253 [Seeking Alpha]

TRACON PHARMS INC (TCON) 
Last tracon pharms inc earnings: 2/27 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: traconpharma.com
Company Research Source: Seeking Alpha
TRACON Pharmaceuticals (NASDAQ:TCONannouncesJNJThe company has launched a search for a licensing partner to develop and commercialize the candidate in China. It does not plan to devote further resources to development if a partnership in China is not realized.TRC253 is small molecule androgen receptor inhibitor discovered and developed by Janssen.TCON is up17% Show less Read more
Impact Snapshot
Event Time:
TCON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for TCON alerts
Opt-in for
TCON alerts

from News Quantified
Opt-in for
TCON alerts

from News Quantified